Published in J Thorac Cardiovasc Surg on August 01, 2001
Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality. J Thorac Cardiovasc Surg (2014) 2.04
Determinants of preventable readmissions in the United States: a systematic review. Implement Sci (2010) 1.36
Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2013) 0.87
The effect of diabetes on hospital readmissions. J Diabetes Sci Technol (2012) 0.80
Higher age predicts adverse outcome and readmission after coronary artery bypass grafting. World J Surg (2003) 0.80
Regionalization in neonatal congenital heart surgery: the impact of distance on outcome after discharge. Pediatr Cardiol (2011) 0.79
Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass. Curr Opin Cardiol (2016) 0.75
Early Rehospitalization After Prolonged Intensive Care Unit Stay Post Cardiac Surgery: Outcomes and Modifiable Risk Factors. J Am Heart Assoc (2017) 0.75
Diabetes and Cardioplegia. J Nat Sci (2017) 0.75
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A (1994) 5.44
Operative outcome and hospital cost. J Thorac Cardiovasc Surg (1998) 2.67
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
A new factor in the production and cure of macrocytic anaemias and its relation to other haemopoietic principles curative in pernicious anaemia. Biochem J (1937) 1.89
Long-term angiographic results of coronary endarterectomy. Ann Thorac Surg (2000) 1.58
Product of a transferred H-2Ld gene acts as restriction element for LCMV-specific killer T cells. Nature (1982) 1.50
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer. J Clin Oncol (1987) 1.47
Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group. J Clin Oncol (1990) 1.39
Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centres. Aust N Z J Med (1995) 1.38
Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest (1993) 1.38
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma. Cancer Treat Rep (1983) 1.32
Monoclonal antibodies reactive with H-2 determinants. Immunogenetics (1983) 1.30
Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res (2005) 1.21
Genetic control of natural cytotoxicity and hybrid resistance. Adv Cancer Res (1980) 1.20
Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent. Br J Cancer (2003) 1.15
A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer. J Clin Oncol (1991) 0.99
Natural killer cell activity during mouse hepatitis virus infection: response in the absence of interferon. Int J Cancer (1983) 0.96
Risk factors for postoperative morbidity. J Thorac Cardiovasc Surg (1996) 0.95
Specific recognition of the product of a transferred major histocompatibility complex gene by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1982) 0.95
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. Cancer Treat Rep (1985) 0.93
Limiting excessive postoperative blood transfusion after cardiac procedures. A review. Tex Heart Inst J (1995) 0.92
Predictors of favorable outcome following naltrexone treatment. Drug Alcohol Depend (1983) 0.91
Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg (1988) 0.91
Monoclonal antibody to native P39 protein from Borrelia burgdorferi. J Clin Microbiol (1994) 0.90
The platelet thrombin receptor and postoperative bleeding. Ann Thorac Surg (1998) 0.90
A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine. Br J Cancer (1982) 0.90
Determination of citrinin in corn and barley. J Assoc Off Anal Chem (1978) 0.89
Inpatient alcohol treatment in a private healthcare setting: which patients benefit and at what cost? Am J Addict (1999) 0.87
Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine). Cancer Res (1989) 0.87
Oropharyngeal dysphagia after cardiac operations. Ann Thorac Surg (2001) 0.87
Quality assurance for digital imaging. J Digit Imaging (1997) 0.85
Anti-CD31 delays platelet adhesion/aggregation at sites of endothelial injury in mouse cerebral arterioles. Am J Pathol (1994) 0.85
Monoclonal antibodies to tubulin and their effects on the movement of reactivated sea urchin spermatozoa. Prog Clin Biol Res (1982) 0.85
Inpatient vs outpatient treatment for substance dependence revisited. Psychiatr Q (1993) 0.85
JMS, successor to cisplatin in advanced ovarian carcinoma? Lancet (1983) 0.84
Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. Cancer Chemother Pharmacol (1999) 0.84
Resistance of H-2 heterozygous mice to parental tumors. II. Characterization of Hh-1 controlled hybrid resistance to syngeneic fibrosarcomas and the EL-4 lymphoma. J Immunol (1977) 0.84
Autologous bone marrow rescue is unnecessary after very-high-dose cyclophosphamide. Lancet (1983) 0.83
High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma. Cancer Chemother Pharmacol (1985) 0.82
Tamoxifen and life-threatening hypercalcaemia. Lancet (1979) 0.82
Plasma pharmacokinetics of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trial. Cancer Chemother Pharmacol (1999) 0.82
2-Amino-5-chlorophenol toxicity in renal cortical slices from Fischer 344 rats: effect of antioxidants and sulfhydryl agents. Toxicol Appl Pharmacol (1999) 0.81
Normal tissue toxicity and antitumour experiments carried out in mice using high-dose cyclophosphamide. Cancer Treat Rev (1983) 0.81
High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the double-standard dose in an assay-dependent manner. Thromb Haemost (2011) 0.81
Ductography is a useful technique in evaluation of abnormal nipple discharge. Am Surg (1996) 0.81
Reduction of carboplatin induced emesis by ondansetron. Br J Cancer (1991) 0.80
Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma. Eur J Cancer (1994) 0.80
High dose cyclophosphamide treatment of human oat cell xenografts in immune deprived mice. Br J Cancer (1983) 0.80
Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trial. Cancer Chemother Pharmacol (1999) 0.80
In Vitro toxicity of 2- and 4-chloroaniline: comparisons with 4-amino-3-chlorophenol, 2-amino-5-chlorophenol and aminophenols. Toxicol In Vitro (1996) 0.79
Detection of IgG-associated determinants in reduced and alkylated preparations of human IgG3 by monoclonal antibodies. Vox Sang (1984) 0.79
The use of antidepressants with methadone in depressed maintenance patients. Ann N Y Acad Sci (1982) 0.78
Prevention of acute deaths in mice after very high dose cyclophosphamide by divided dose schedule. Br J Cancer (1984) 0.77
1988: Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Updated in 1995. Ann Thorac Surg (1995) 0.77
Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancer. Cancer Treat Rev (1985) 0.77
Structure-activity-relationships of certain hallucinogenic substances based on brain levels. Life Sci (1977) 0.77
Incidence of personality disorders in cocaine vs. alcohol-dependent females. NIDA Res Monogr (1990) 0.76
Impulsivity and substance abusers: changes with treatment and recovery. NIDA Res Monogr (1990) 0.75
Herpes simplex virus hepatitis after renal transplantation. Transpl Infect Dis (2008) 0.75
Platelet aggregation abnormalities after cardiopulmonary bypass. Blood (1994) 0.75
Macromerine, normacromerine and bisnormacromerine: non-psychoactive methylated derivatives of norepinephrine. Psychopharmacologia (1973) 0.75
Metastasizing leiomyoma of the uterus. Aust N Z J Obstet Gynaecol (1988) 0.75
The Lancet, 311-314; A new factor in the production and cure of certain macrocytic anaemias. Nutr Rev (1979) 0.75
Predictors of postoperative ventricular dysrhythmias: a multivariate study. J Cardiovasc Surg (Torino) (1991) 0.75
Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics. N Z Med J (1992) 0.75
High-dose cyclophosphamide (7 g/m2) with or without autologous bone marrow rescue after conventional chemotherapy in the treatment of patients with small cell lung cancer. Cancer Treat Rev (1983) 0.75
Interaction of Zn2+ with guinea-pig C5 convertase and guinea-pig C5. Mol Immunol (1984) 0.75
The natural history of outpatient alcohol and drug abuse treatment in a private healthcare setting. Alcohol Clin Exp Res (1996) 0.75
"High"- and "low"-potency antipsychotic drugs. Psychopharmacol Bull (1980) 0.75
HIV-risk behaviors among a middle class population: a preliminary investigation among adolescent vs. adult substance users. NIDA Res Monogr (1990) 0.75
Penetration of some O-and/or N-methylated norepinephrine derivatives through the rat blood brain barrier. Res Commun Chem Pathol Pharmacol (1977) 0.75
Cephaloridine in vitro toxicity and accumulation in renal slices from normoglycemic and diabetic rats. Fundam Appl Toxicol (1997) 0.75
Verapamil prophylaxis for postoperative atrial dysrhythmias: a prospective, randomized, double-blind study using drug level monitoring. Ann Thorac Surg (1987) 0.75
Immunity to MCA-induced rat sarcomas: analysis of in vivo and in vitro results. Int J Cancer (1977) 0.75
Cost-effectiveness of minimally invasive cardiac operations. Heart Surg Forum (2001) 0.75
The phylogeny of mammalian histocompatibility immunogenes. Transplant Proc (1979) 0.75
The effect of ethylenedinitrilotetraacetic acid (EDTA) on the reaction between the guinea-pig C5 convertase and guinea-pig C5. Mol Immunol (1984) 0.75
H-2D-associated hybrid resistance to EL4. Transplant Proc (1979) 0.75
Guide to practical clinical psychopharmacology. Pa Med (1979) 0.75
HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours. N Z Med J (1993) 0.75
A new murine lymphocyte alloantigen, Ly-27.2. Immunogenetics (1986) 0.75
Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma. Eur J Cancer (1980) 0.75
Treatment of mixed abusers in methadone maintenance: role of psychiatric factors. Ann N Y Acad Sci (1982) 0.75
beta-Hydroxylation as a possible detoxification mechanism: role in schizophrenia. Biol Psychiatry (1977) 0.75
Patient assessment of a combined medical and nursing preparation to cytotoxic chemotherapy. Support Care Cancer (1993) 0.75
Physiological disposition of isoergine (from Argyreia nervosa (Burm. f.) Bojer Convolvulaceae) and its effect on the conditioned avoidance response in rats. Psychopharmacologia (1972) 0.75
Palliation of biliary obstruction in patients with advanced breast cancer using endoscopic stents. Br J Surg (1993) 0.75
Thrombin receptor-related hemostatic defect after cardiopulmonary bypass. Semin Thromb Hemost (1996) 0.75
Predictors of favorable outcome following naltrexone treatment. NIDA Res Monogr (1983) 0.75